Reaktionsgleichung
[NH2:1][C:2]1[S:3][C:4]2[C:10](=[O:11])[CH2:9][C:8]([CH3:13])([CH3:12])[CH2:7][C:5]=2[N:6]=1.[Br:14][C:15]1[CH:16]=[C:17]([S:21](Cl)(=[O:23])=[O:22])[S:18][C:19]=1[Cl:20]>>[Br:14][C:15]1[CH:16]=[C:17]([S:21]([NH:1][C:2]2[S:3][C:4]3[C:10](=[O:11])[CH2:9][C:8]([CH3:13])([CH3:12])[CH2:7][C:5]=3[N:6]=2)(=[O:23])=[O:22])[S:18][C:19]=1[Cl:20]Komponenten
3
Versuchsvorschrift
The title compound was prepared from 2-amino-5,5-dimethyl-5,6-dihydro-1,3-benzothiazol-7(4H)one (53 mg) and 4-bromo-5-chlorothiophene-2-sulfonyl chloride (80 mg) as described in the synthetic METHOD B to give a white-yellow solid (47.1 mg) with purity >90%: MS (pos) m/z 455.2, 457.2.
Quellen und Nachweise
- ORD-Eintrag
- ord-d0bfe556ff1f47d5a89fab6dbb6c63b6
- Quelldatensatz
- uspto-grants-2006_04
- Patentnummer
- US07030135B2
Verknüpfte Notizen
Wird geladen…